Arbutus Biopharma Corporation ABUS Convertible Preferred Stock Authorized Shares
Convertible Preferred Stock Authorized Shares at other companies
Other financials
Where this comes from
Reported directly by Arbutus Biopharma Corporation in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arbutus Biopharma Corporation's convertible preferred stock authorized shares.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arbutus Biopharma Corporation's convertible preferred stock authorized shares?
- Arbutus Biopharma Corporation (ABUS) reported convertible preferred stock authorized shares of 1.2M in Q1 2026.
- How has Arbutus Biopharma Corporation's convertible preferred stock authorized shares changed year-over-year?
- Arbutus Biopharma Corporation's convertible preferred stock authorized shares decreased by 0.0% year-over-year, from 1.2M to 1.2M.
- What does convertible preferred stock authorized shares mean?
- Maximum number of convertible preferred shares the company is authorized to issue under its corporate charter.